Pharmaceutical Executive, Apr 1, 2012 - Pharmaceutical Executive

ADVERTISEMENT
Pharmaceutical Executive, Apr 1, 2012
Features
HBA Woman of the Year 2012
By William Looney
Throughout her life, HBA Woman of the Year Carolyn Buck-Luce has made progress by recognizing that when one door closes, another one opens.
Emerging Markets: Setting a New Agenda
By William Looney
India's most prominent scientist, Dr R.A. Mashelkar, President of the Global Research Alliance, on delivering medicines profitably but cheaply to low income countries.
Pharm Exec Ad Stars 2012
By Jennifer Ringler , Ben Comer
This year's Ad Stars embrace creativity through the eyes of the patients. Ben Comer and Jennifer Ringler report.
Columns
Shortages and Sunshine
By Jill Wechsler
Disclosure rules the day, as industry confronts demands to report supply problems, results of clinical trials, and payment to doctors.
Providing Access Now
While regulatory frameworks and medical practices differ between countries, many patients still need early access to new drugs. Industry can help.
Scotland, Independence, and Pharma
By Ben Comer
What does a Scottish vote for independence mean for Big Pharma investment and healthcare funding and delivery in the UK?
Navigating M&A Complexities
Too often in M&A or product-linked carve-outs, executives overlook the complexities of disentangling operations and the effort required for regulatory re-registration and labeling changes.
Think Digital First
By Bill Drummy
While what is considered 'traditional' marketing has evolved over the years, it's clear that a digital strategy is an absolute necessity to compete today—not just tomorrow.
Medical Meetings
Medical Meetings: Docs Speak Out
Three physicians took the stage at the fourth annual West Coast Life Sciences Meeting Management Forum to explain to pharma and life sciences planners their perspective on healthcare reform, online versus live education, and what it takes to get them to participate in medical meetings in today's increasingly transparent environment.
Country Report
Country Report: Ukraine
Despite the severe blow to its economy, Ukraine has been recovering at a faster rate than its Western European counterparts
From the Editor
IP: Time for a Reset?
By William Looney
Patents are the chief incentive for drug development. Industry should educate stakeholders about IP protection as a crucial driver of innovation, before it's too late.

ADVERTISEMENT

Click here